Protect Yourself While There’s Still Time …

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.

Kevin Michael Mullins net worth and biography

Kevin Mullins Biography and Net Worth

Insider of LifeStance Health Group

Kevin has over 10 years of experience in healthcare, as both an operator and investor. He joined LifeStance Health in early 2017 and focuses acquiring and integrating new behavioral health practices.

Prior to joining LifeStance, Kevin was a Vice President at Summit Partners where he focused on investments in the healthcare services and life sciences sector. While at Summit, he was part of the team that founded MedSpring Urgent Care, which operates 50 urgent care centers in 3 states and was acquired by Fresenius Medical Care. Previously, Kevin worked at Curaspan and in the Healthcare Investment Banking Group at Leerink Partners. He holds a BA in physics and economics from Bowdoin College and a MBA from the Stanford Graduate School of Business.

Kevin enjoys listening to sports radio, CrossFit, biking and all Boston sports.

What is Kevin Michael Mullins' net worth?: The estimated net worth of Kevin Michael Mullins is at least $29.42 million as of March 14th, 2024. Mr. Mullins owns 4,745,352 shares of LifeStance Health Group stock worth more than $29,421,182 as of April 27th. This net worth estimate does not reflect any other assets that Mr. Mullins may own. Learn More about Kevin Michael Mullins' net worth.
How old is Kevin Michael Mullins?: Mr. Mullins is currently 39 years old. There are 5 older executives and no younger executives at LifeStance Health Group. The oldest executive at LifeStance Health Group is Mr. Kenneth Alan Burdick, CEO & Chairman, who is 65 years old. Learn More on Kevin Michael Mullins' age.
How do I contact Kevin Michael Mullins?: The corporate mailing address for Mr. Mullins and other LifeStance Health Group executives is , , . LifeStance Health Group can also be reached via phone at 602-767-2100 and via email at [email protected]. Learn More on Kevin Michael Mullins' contact information.
Has Kevin Michael Mullins been buying or selling shares of LifeStance Health Group?: Kevin Michael Mullins has not been actively trading shares of LifeStance Health Group in the last ninety days. Most recently, Kevin Michael Mullins sold 44,540 shares of the business's stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $6.33, for a transaction totalling $281,938.20. Following the completion of the sale, the insider now directly owns 4,745,352 shares of the company's stock, valued at $30,038,078.16. Learn More on Kevin Michael Mullins' trading history.
Who are LifeStance Health Group's active insiders?: LifeStance Health Group's insider roster includes Jeffrey Crisan (Director), Kevin Mullins (Insider), Ryan Pardo (Chief Legal Officer), Anisha Patel-Dunn (Chief Medical Officer), Danish Qureshi (President and Chief Operating Officer), and Ann Varanakis (Chief People Officer). Learn More on LifeStance Health Group's active insiders.
Are insiders buying or selling shares of LifeStance Health Group?: In the last twelve months, insiders at the sold shares 20 times. They sold a total of 1,018,813 shares worth more than $7,895,861.68. The most recent insider tranaction occured on April, 1st when insider Danish J Qureshi sold 12,965 shares worth more than $76,882.45. Insiders at LifeStance Health Group own 8.5% of the company. Learn More about insider trades at LifeStance Health Group.
Information on this page was last updated on 4/1/2024.

Kevin Michael Mullins Insider Trading History at LifeStance Health Group

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/14/2024	Sell	44,540	$6.33	$281,938.20	4,745,352
3/1/2024	Sell	115,136	$8.02	$923,390.72	4,575,480
12/1/2023	Sell	113,334	$6.54	$741,204.36	4,690,616
11/6/2023	Sell	300	$6.12	$1,836.00	4,836,006
11/3/2023	Sell	80,977	$6.13	$496,389.01	4,836,306
10/2/2023	Sell	113,333	$6.61	$749,131.13	4,917,283
7/5/2023	Sell	150,000	$8.72	$1,308,000.00	5,166,016
7/3/2023	Sell	54,600	$9.00	$491,400.00	5,316,016
6/23/2023	Sell	65,832	$9.02	$593,804.64	5,370,616
4/3/2023	Sell	97,266	$7.43	$722,686.38	5,512,581
3/16/2023	Sell	43,705	$6.14	$268,348.70	5,609,847
3/14/2023	Sell	800	$6.11	$4,888.00	5,653,752
3/8/2023	Sell	122,295	$6.12	$748,445.40	5,654,552
9/30/2022	Sell	82,520	$7.03	$580,115.60	5,584,540
4/20/2022	Sell	46,283	$10.68	$494,302.44	5,669,472

Kevin Michael Mullins Buying and Selling Activity at LifeStance Health Group

LifeStance Health Group Company Overview

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Today's Range

Now: $6.20

$6.06

$6.25

50 Day Range

MA: $6.44

$5.62

$8.71

2 Week Range

Now: $6.20

$4.74

$9.59

Volume

647,258 shs

Average Volume

1,301,276 shs

Market Capitalization

$2.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Protect Yourself While There’s Still Time …

From Weiss Ratings | Ad